Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology Jun 10;33(17):1936-1942
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID25897153
- PMC
- PMC4451176
- Study Number(s)
- E2496
Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stage I or II locally extensive, bulky mediastinal hodgkins lymphoma: a subset analysis of the North American Intergroup E2496 trial
- Journal / Conference
- Blood Feb 5;125(6):992-998
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID25422100
- PMC
- PMC4319239
- Study Number(s)
- S0016, S9800, S9911
Elevated serum levels of IL-2R, IL-1RA and CXCL9 are associated with a poor prognosis in follicular lymphoma
- Journal / Conference
- Journal of Clinical Oncology May 10;33(14):1601-1608
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25847934
- PMC
- PMC4417730
- Study Number(s)
- S0925
SWOG S0925: A randomized phase 2 study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer
- Journal / Conference
- Journal of Clinical Oncology Dec 1;33(34):4093-4098
- Year
- 2015
- Research Committee(s)
- Brain
- PMID
- PMID26527781
- PMC
- PMC4669593
- Study Number(s)
- SWOG-9005
SWOG S9005: double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma
- Journal / Conference
- PLOS ONE 2015 May 8;10(5):e0126672
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25955319
- PMC
- PMC4425512
- Study Number(s)
- SWOG-9217
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Surgical Oncology Jun;111(7):923-928
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25873574
- PMC
- PMC4602027
- Study Number(s)
- 4B951
Variability in surgical quality in a phase III prospective clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder
- Journal / Conference
- Journal of Clinical Oncology 33 (suppl 3; abstr TPS790); ASCO GI Cancers Symposium (January 15-17, 2015, in San Francisco, CA), TIPS poster;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1406
S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (mCRC)
- Journal / Conference
- Journal of Clinical Oncology 33(2):149-155
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25332254
- PMC
- PMC4279234
- Study Number(s)
- S1007
Tumor marker usage and medical care costs among older early-stage breast cancer survivors
- Journal / Conference
- British Journal of Haematology Nov;171(4):530-538
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID26343802
- PMC
- PMC4881845
- Study Number(s)
- E2496
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era
- Journal / Conference
- Journal of Clinical Oncology 33 (suppl 7; abstr 152);ASCO GU Cancers Sympos (February 26-28, 2015, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1014